Short Takes
Video Interviews With Industry Leaders
The Digital Health Coalition partners with a wide array of pharmaceutical industry leaders and key stakeholders to facilitate and disseminate insights on a range of topics related to digital pharmaceutical marketing innovation.
- View Interviews
Recent Short Takes
Short Takes Archive
-
- Michael Sivak, Senior Director, Customer Experience
& Enterprise Digital Capabilities
AstraZeneca - Dr Jenny YU, Chief Health Officer Healthline
- Meghan Sarli, Principal, Marketing Strategy & Client Insights PatientPoint
- Dr Ashish Rana, Medical Advisory Board Sermo
- Brandi Ascione, EVP, Managing Director, Underscore Marketing
- Jay Carter, EVP Business Development Juice Pharma
- Milet Koo, Team Lead Social Media Genetech
- Jim Delash, Multi-Channel Marketing Director GSK
- Richard Schwartz, Life Sciences Industry Practice Lead Qualtrics
- Fay McCray, Vice President & Head of Health Equity and Social Impact Healthline Media
- Fred Bennett, Chief Digital Officer, BGB Group
- Tim Panetello, CEO, Relevate Health
- Louis Naimoli, Director, Programmatic Sales and Business Development, Haylo
- Erica Taylor, VP, Chief Marketing Officer, Genentech
- Jen Alper, Senior Director, US Women’s Health Portfolio Team Lead Pfizer
- Meghan Rivera, US Managing Director Organon
- Marianne Swift, Director of Client Partnerships Spotify
- William Febbo, CEO OptimizeRx
- Nik Kolatker, Vice President, US Medical Affairs Genentech
- Kristi Veitch, Executive Vice President, Human Resources Intouch Group
- Peter Kirk, Founder Sermo
- Peter Freidman, Chairman and CEO Liveworld
- Web Sun, CEO Komodo Health
- Heidi Anderson Hupe, SVP, ASO Strategy Teladoc
- Derek Choy, Co-Founder & COO Aktana
- Richard Schwartz, Life Sciences and Medical Device Industry Cx Practice Lead Medallia
- Spencer Curtis, Head of Digital Strategy, Otsuka Pharmaceutical
- Monique Levy, Chief Commercial and Strategy Officer, Woebot Health
- Michael Sivak, Senior Director, Customer Experience
Bill Veltre
EVP, Head of Media, Deerfield Agency
View LinkedIn
Mark Bard and Bill Veltre discussed the evolving landscape of digital trends and data-driven strategies within the pharmaceutical industry. Veltre emphasized the importance of unlocking the potential of data and utilizing it to drive brand success through attribution and collaboration across various touchpoints. They also explored the transition from traditional to digital mindsets in marketing and the significance of partnerships between agencies and pharmaceutical companies in delivering purposeful and meaningful interactions with healthcare professionals. Looking ahead, they highlighted the necessity for agility, innovation, and a deep understanding of evolving customer expectations to drive business impact in the rapidly changing healthcare landscape.
Hansa Bhargava, MD
Chief Clinical Strategy & Innovation
Healio
View LinkedIn
This interview between Mark Bard, Co-Founder of The DHC Group and Dr. Hansa Bhargava, Chief Clinical Strategy and Innovation at Healio, covers several key topics related to healthcare and technology. Dr. Bhargava discussed her motivation for pursuing medicine, particularly in pediatrics.
Dr. Bhargava highlights physician burnout as a major issue, citing administrative burdens like EMRs as a leading cause. She expresses excitement about the potential of AI and emerging technologies to reduce burnout and improve clinical efficiency through applications like transcription, prior authorization, and clinical decision support. She also addresses the double-edged nature of patient access to online health information, emphasizing the need for vetted, trustworthy sources. Additionally, Dr. Bhargava speaks about using technology to reach underserved populations, improve clinical trial diversity, and enhance access to care through solutions like telehealth and digital therapeutics – however, stressing the importance of involving physicians in the development of new technologies and providing proper education to ensure responsible adoption of AI tools.
Elaine Gamble
Senior Marketing
and Omnichannel Engagement Leader
View LinkedIn
This interview between Mark Bard, Co-Founder of The DHC Group and Elaine Gamble, former Head of Omnichannel Engagement at Otsuka, CNS Division, focuses on Elaine’s experience in omni-channel marketing and excellence in the pharmaceutical industry.
Key topics discussed include motivations for early roles, similarities and differences across companies, executing cohesive omni-channel strategies, modular content approaches, and addressing social determinants of health through personalized experiences. Elaine shares insights on fostering high-functioning teams, effective MLR onboarding processes, leveraging technology for modular content, and using data to predict pivotal decision moments and tailoring messaging for underserved populations.
Sara Farag, MD, FACOG
Medical Advisory Board
Sermo
View LinkedIn
The conversation between Mark Bard and Dr. Farag of the Sermo Medical Advisory Board highlights the evolving dynamics of rep interactions, transitioning from in-person to digital during COVID and now incorporating both methods post-COVID.
Dr. Farag emphasizes the value of rep interactions for staying updated on new medications/tools, establishing relationships, and accessing resources like medical liaisons and patient support tools.
Dr. Farag shares her perspective on how digital communication complements traditional interactions, enhancing efficiency by allowing her to access information and benefiting from tailored approaches to pharma-led physician education and support.
Jeff Davis
General Manager, Biopharma
ixlayer
View LinkedIn
In this interview between Mark Bard, Co-Founder of The DHC Group and Jeff Davis, General Manager of Biopharma at ixlayer, the discussion centers around rethinking diagnostic testing and how it can improve the healthcare triple aim of lowering costs, improving outcomes, and enhancing patient experience.
Jeff explains how building a platform to enable remote diagnostic testing through partnerships with labs optimizes the patient experience – this allows tests to be developed and taken at home, with results connected to care providers in the health ecosystem. The two also discussed how testing innovations can help patients with information earlier in their care journey, and how remote testing could improve access issues by reaching underserved populations and addressing social determinants of health.
Finally, Mark and Jeff covered opportunities for data insights and how biopharma companies could tailor the testing experience for their patients while maintaining strong privacy standards.
Ryan Billings
Head of Commercial Innovation &
US Established Brands Business Unit
Organon View LinkedIn
Mark Bard sat down with Ryan Billings, head of Commercial Innovation at Organon. The two started by discussing the unique aspects of Billings’ role at Organon – a [global health company] that focuses on women’s health, an underserved area in the pharmaceutical industry.
Billings talks about the challenges of partnering with innovative companies in the pharmaceutical industry but believes pharma can partner with rapidly growing innovative companies by focusing on their value add in clinical innovation and products, rather than trying to build everything themselves. In terms of both customer experience innovation and a marketing efficiency, Billings mentions the importance of AI, which he refers to as “amplified intelligence.”
Finally, Billings offers advice to those looking to stay ahead in terms of innovation and knowledge in the industry.
Receive exclusive interviews and articles — delivered straight to your inbox every month.